Animal-models of ejaculatory behavior

被引:40
作者
Pattij, T
Olivier, B
Waldinger, MD
机构
[1] Leyenburg Hosp, Dept Psychiat & Neurosexol, NL-2545 CH The Hague, Netherlands
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[3] Univ Utrecht, Inst Pharmaceut Sci, Dept Psychopharmacol, Utrecht, Netherlands
[4] Univ Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
关键词
premature ejaculation; animal model; SSRI; serotonine;
D O I
10.2174/138161205774913363
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Premature ejaculation is generally regarded the most frequent male ejaculatory complaint and has been considered a psychosexual disorder with psychogenic actiology. The efficacy of various antidepressants, however, to delay ejaculation in men and to pharmacologically treat premature ejaculation suggests a strong neurobiological involvement. Most of our current understanding of the neurobiology and neuroanatomy of sexual behavior and ejaculatory function has been derived from preclinical studies using several laboratory species. In the present paper we will review the various animal models that have been developed to further study ejaculatory function in the laboratory rat. In addition, we will briefly review the effects of serotonergic antidepressants and serotonergic compounds on sexual and ejaculatory behavior. Together, these preclinical studies may contribute to a better understanding of the neurobiology of ejaculation and help the development of novel drug targets to treat ejaculatory disorders such as premature ejaculation.
引用
收藏
页码:4069 / 4077
页数:9
相关论文
共 85 条
[71]   Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline [J].
Waldinger, MD ;
Hengeveld, MW ;
Zwinderman, AH ;
Olivier, B .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) :274-281
[72]   Familial occurrence of primary premature ejaculation [J].
Waldinger, MD ;
Rietschel, M ;
Nothen, MM ;
Hengeveld, MW ;
Olivier, B .
PSYCHIATRIC GENETICS, 1998, 8 (01) :37-40
[73]   The neurobiological approach to premature ejaculation [J].
Waldinger, MD .
JOURNAL OF UROLOGY, 2002, 168 (06) :2359-2367
[74]   The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment [J].
Waldinger, MD ;
van de Plas, A ;
Pattij, T ;
van Oorschot, R ;
Coolen, LM ;
Veening, JG ;
Olivier, B .
PSYCHOPHARMACOLOGY, 2002, 160 (03) :283-289
[75]   SSRIs and ejaculation: A double-blind, randomized, fixed-dose study with paroxetine and citalopram [J].
Waldinger, MD ;
Zwinderman, AH ;
Olivier, B .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (06) :556-560
[76]   Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system [J].
Waldinger, MD ;
Berendsen, HHG ;
Blok, BFM ;
Olivier, B ;
Holstege, G .
BEHAVIOURAL BRAIN RESEARCH, 1998, 92 (02) :111-118
[77]  
Waldinger MD, 1998, INT CLIN PSYCHOPHARM, V13, pS27
[78]   Lifelong premature ejaculation: from authority-based to evidence-based medicine [J].
Waldinger, MD .
BJU INTERNATIONAL, 2004, 93 (02) :201-207
[79]   Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology [J].
Waldinger, MD .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (05) :309-313
[80]   Antidepressants and ejaculation: A double-blind, randomized, fixed-dose study with mirtazapine and paroxetine [J].
Waldinger, MD ;
Zwinderman, AH ;
Olivier, B .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) :467-470